2-drug combo may slow thyroid cancer
A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a new study in Science Translational Medicine (January 2, 2013, Vol. 5:166, p. 166ra3). The two drugs together resulted in greater anticancer activity in ATC than either drug alone, lead researcher Keith Bible, MD, PhD, a Mayo Clinic oncologist, noted in a press release. Anaplastic thyroid cancer is a rare but aggressive

